Search results for “Sideroblastic anemia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 33 patents, we discovered top 12 key players by total patent application. Acceleron Pharma, Inc., Takeda Pharmaceutical Co., Ltd., FerroKin BioSciences, Inc. are dominant in this area. They take 66.67% of the total patent filing.
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 14
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 6
FerroKin BioSciences, Inc.
Massachusetts, United States
Patent: 2
EdiGene (GuangZhou) Inc.
Guangdong Sheng, China
Patent: 2
Matsui KK
Hokkaido, Japan
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 1
ethris GmbH
Bayern, Germany
Patent: 1
Interpharm Laboratories Ltd.
Israel
Patent: 1
Beijing Bowei Hi-Tech Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 20 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing Acceleron Pharma, Inc., Kyoto University, The Children's Hospital of Philadelphia take 55.00% of patent filing during this period.
Acceleron Pharma, Inc.
Massachusetts, United States
Patent: 5
Kyoto University
Kyoto-fu, Japan
Patent: 3
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 3
EdiGene (GuangZhou) Inc.
Guangdong Sheng, China
Patent: 2
Naval Research Laboratory
District of Columbia, United States
Patent: 1
Brigham Young University
Utah, United States
Patent: 1
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 1
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Tianjin JiankangHuamei Medical Diagnostic Technology Co.Ltd
Tianjin Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 20 patents in last 5 years, we discover 10 new entrants. Kyoto University, The Children's Hospital of Philadelphia, EdiGene (GuangZhou) Inc. are the most active new entrants in this area.
Kyoto University
Kyoto-fu, Japan
Patent: 3
The Children's Hospital of Philadelphia
Pennsylvania, United States
Patent: 3
EdiGene (GuangZhou) Inc.
Guangdong Sheng, China
Patent: 2
Naval Research Laboratory
District of Columbia, United States
Patent: 1
Brigham Young University
Utah, United States
Patent: 1
Protagonist Therapeutics, Inc.
Queensland, Australia
Patent: 1
TRUSTEES OF THE UNIV OF PENNSYLVANIA
Pennsylvania, United States
Patent: 1
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Tianjin JiankangHuamei Medical Diagnostic Technology Co.Ltd
Tianjin Shi, China
Patent: 1
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Kyoto University
Kyoto-fu, Japan
Patent: 3
Brigham Young University
Utah, United States
Patent: 1
Dalhousie University
Canada
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: